Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine [2]

British Journal of Haematology

Volumn 112, Issue 4, 2001, Pages 1083-1085

  Robak, T ^a   Kasznicki, M ^a   Blonski J Z ^a   Dmoszynska A ^b   Skotnicki, A B ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Medical University Lublin   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Chronic lymphocytic leukaemia; Cladribine; Cyclosporine A; PRCA; Purine analogues

Indexed keywords

CLADRIBINE;

ADULT; AGED; ANEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DRUG EFFECT; ERYTHROCYTE APLASIA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035047759     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02622-2.x     Document Type: Letter

References (7)

1. Pure red cell aplasia in patients with chronic lymphocytic leukemia
2. Cytopenia and fludarabine
3. Pure red cell aplasia: Clinical features and treatment results in 16 cases
4. Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia
5. Treatment of red cell aplasia in CLL with fludarabine
6. Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - Updated results of the multicentre study of 378 patients
7. Refractory pure red cell aplasia associated with B-CLL: Successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin